2025-04-13 23:24:40
Latest Post
IPO-bound Belrise Industries Ltd completes strategic acquisition of H-One India Private Limited
Mitsu Chem Plast Eyes ₹ 1,000 Cr Revenue by 2028
Aurobindo Pharma receives final ANDA approval for Rivaroxaban Tablets USP, 2.5mg
NHPC Ltd commissions commercial operation of 107.14 MW of 300 MW Karnisar Solar Power Plant
Nureca Limited's Manufacturing Subsidiary Secures US FDA Registration
Stock Report
Surbhi Industries Ltd Q3FY23 loss at Rs. 1.87 crore
Posted On : 2023-02-02 20:03:34( TIMEZONE : IST )
has reported Standalone financial results for the period ended December 31, 2022.
Financial Results (Q3 FY2023) - QoQ Comparison
The company has reported total income of Rs. 4.4282 crores during the period ended December 31, 2022 as compared to Rs. 8.5143 crores during the period ended September 30, 2022.
The company has posted net profit / (loss) of Rs. -1.8741 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs. 1.5744 crores for the period ended September 30, 2022.
The company has reported EPS of Rs. -5.45 for the period ended December 31, 2022 as compared to Rs. 4.58 for the period ended September 30, 2022.
| Financials | Q3 FY2023 | Q2 FY2023 | % Change |
| Total Income | ₹4.4282 crs | ₹8.5143 crs |  -47.99% |
| Net Profit | ₹-1.8741 crs | ₹1.5744 crs | -219.04% |
| EPS | ₹-5.45 | ₹4.58 | -219.00% |
Financial Results (Q3 FY2023) - YoY Comparison
The company has reported total income of Rs.4.4282 crores during the period ended December 31, 2022 as compared to Rs.9.8032 crores during the period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.-1.8741 crores for the period ended December 31, 2022 as against net profit / (loss) of Rs.1.1339 crores for the period ended December 31, 2021.
The company has reported EPS of Rs.-5.45 for the period ended December 31, 2022 as compared to Rs.3.30 for the period ended December 31, 2021.
| Financials | Q3 FY2023 | Q3 FY2022 | % Change |
| Total Income | ₹4.4282 crs | ₹9.8032 crs | -54.83% |
| Net Profit | ₹-1.8741 crs | ₹1.1339 crs | -265.28% |
| EPS | ₹-5.45 | ₹3.30 | -265.15% |
Financial Results (9 Months Ended FY2023) - YoY Comparison
The company has reported total income of Rs.20.3558 crores during the 9 Months period ended December 31, 2022 as compared to Rs.20.6401 crores during the 9 Months period ended December 31, 2021.
The company has posted net profit / (loss) of Rs.0.0150 crores for the 9 Months period ended December 31, 2022 as against net profit / (loss) of Rs.2.3713 crores for the 9 Months period ended December 31, 2021.
The company has reported EPS of Rs.0.04 for the 9 Months period ended December 31, 2022 as compared to Rs.6.90 for the 9 Months period ended December 31, 2021.
| Financials | 9 Months Ended FY2023 | 9 Months Ended FY2022 | % Change |
| Total Income | ₹20.3558 crs | ₹20.6401 crs | -1.38% |
| Net Profit | ₹0.0150 crs | ₹2.3713 crs | -99.37% |
| EPS | ₹0.04 | ₹6.90 | -99.42% |
